Phase 2 Clinical Trials
Filters
Sort by
- All
- ASX Listed
- Clinical Development
- Commercialisation
- Early Stage
- Exploration
- Fund
- Growth Stage
- Initial Coin Offering (ICO)
- Initial Public Offering (IPO)
- Late-Clinical Stage
- Listed
- Mature Stage
- Phase 2 Clinical Trials
- Pre-Clinical Stage
- Pre-ICO
- Pre-IPO
- Pre-Registration
- Pre-Series A
- Project Financing
- Research and Development
- Security Token Offering (STO)
- Seed Capital
- Series A
- Series B
- Series C
- SGX Listed
- Startup
Proteolytics Pty Ltd
Biotechnology / Life Sciences / Pharmaceuticals Proteolytics Pty Ltd, based in Perth, is developing and commercialising OPAL-A, a proprietary botanical extract from pawpaw fruit to treat hard-to-heal wounds and skin disorders.…
Zucero Therapeutics Limited
Healthcare / Biotechnology / Pharmaceuticals Zucero is an Australian-based biotechnology company focused on the development of pixatimod, an immunotherapy for the treatment of cancer. Zucero’s objective is to modulate the…
Immutep Limited (ASX: IMM)
Healthcare / Biotechnology / Pharmaceuticals Immutep is a biotechnology company developing novel immunotherapy treatments for cancer and autoimmune disease, with operations in Europe, Australia, and the U.S. Immutep is the…
Imugene Ltd (ASX: IMU)
Biotechnology Imugene is a clinical stage immuno-oncology company. Its lead product is HER-Vaxx, a B Cell peptide vaccine for the treatment of gastric cancer. The company…
Prescient Therapeutics (ASX: PTX)
Healthcare / Biotechnology / Pharmaceuticals Prescient Therapeutics is a clinical stage oncology company developing targeted therapies that address specific mutations that drive cancer and contribute to resistance. Prescient’s lead drug…
Dimerix Limited (ASX:DXB)
Healthcare / Biotechnology Dimerix Limited (ASX: DXB) is a clinical-stage drug development company discovering and developing new therapeutic treatments identified using its proprietary drug discovery platform. Our lead…
Loading...